Llwytho...
免疫组化法检测NSCLC患者EGFR突变的相关研究
BACKGROUND AND OBJECTIVE: Patients with non-small cell lung cancer (NSCLC) harboring mutations of the epidermal growth factor receptor (EGFR) respond well to EGFR-tyrosine kinase inhibitor therapy. Immunohistochemistry (IHC) is a simple and widely used technique in clinical pathology laboratories. I...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Zhongguo Fei Ai Za Zhi |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
中国肺癌杂志编辑部
2015
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6000282/ https://ncbi.nlm.nih.gov/pubmed/25936885 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3779/j.issn.1009-3419.2015.04.01 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|